PL3085370T3 - Kalebina A do indukowania lipolizy - Google Patents

Kalebina A do indukowania lipolizy

Info

Publication number
PL3085370T3
PL3085370T3 PL15173299T PL15173299T PL3085370T3 PL 3085370 T3 PL3085370 T3 PL 3085370T3 PL 15173299 T PL15173299 T PL 15173299T PL 15173299 T PL15173299 T PL 15173299T PL 3085370 T3 PL3085370 T3 PL 3085370T3
Authority
PL
Poland
Prior art keywords
calebin
inducing lipolysis
lipolysis
inducing
Prior art date
Application number
PL15173299T
Other languages
English (en)
Inventor
Muhammed Majeed
Anju Majeed
Kalyanam Nagabhushanam
Original Assignee
Anju Majeed
Muhammed Majeed
Kalyanam Nagabhushanam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/690,438 external-priority patent/US9737502B2/en
Application filed by Anju Majeed, Muhammed Majeed, Kalyanam Nagabhushanam filed Critical Anju Majeed
Publication of PL3085370T3 publication Critical patent/PL3085370T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL15173299T 2015-04-19 2015-06-23 Kalebina A do indukowania lipolizy PL3085370T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/690,438 US9737502B2 (en) 2011-01-10 2015-04-19 Calebin A for hepatic steatosis
EP15173299.7A EP3085370B1 (en) 2015-04-19 2015-06-23 Calebin a for inducing lipolysis

Publications (1)

Publication Number Publication Date
PL3085370T3 true PL3085370T3 (pl) 2019-04-30

Family

ID=53513962

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15173299T PL3085370T3 (pl) 2015-04-19 2015-06-23 Kalebina A do indukowania lipolizy

Country Status (12)

Country Link
EP (1) EP3085370B1 (pl)
KR (1) KR101763474B1 (pl)
AU (1) AU2015203157A1 (pl)
CA (1) CA2893321C (pl)
ES (1) ES2702629T3 (pl)
MY (1) MY182000A (pl)
PH (1) PH12015000188B1 (pl)
PL (1) PL3085370T3 (pl)
PT (1) PT3085370T (pl)
RU (1) RU2643297C2 (pl)
SG (1) SG10201503805XA (pl)
TR (1) TR201819806T4 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3219750A1 (en) * 2021-06-22 2022-12-29 Muhammed Majeed Calebin-a for thermogenesis and dysbiosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007076027A2 (en) * 2005-12-22 2007-07-05 Fmc Corporation Novel formulations of bifenthrin and enriched cypermethrin
US9328330B2 (en) * 2011-01-10 2016-05-03 Sami Labs Limited Anti-obesity potential of Calebin A
RU2543334C1 (ru) * 2011-01-10 2015-02-27 Мухаммед Маджид Потенциал калебина а в качестве средства против ожирения
RU2538221C1 (ru) * 2013-08-06 2015-01-10 Строяковский Валентин Меерович Способ лечения неалкогольного жирового гепатоза при сахарном диабете 2 типа
US9668999B2 (en) * 2014-04-23 2017-06-06 Semi Labs Limited Method for the treatment of hypercholesterolemia

Also Published As

Publication number Publication date
EP3085370B1 (en) 2018-09-26
PT3085370T (pt) 2018-12-24
KR20160124401A (ko) 2016-10-27
AU2015203157A1 (en) 2016-11-03
SG10201503805XA (en) 2016-11-29
KR101763474B1 (ko) 2017-07-31
EP3085370A1 (en) 2016-10-26
CA2893321A1 (en) 2016-10-19
RU2015126932A (ru) 2017-01-13
RU2643297C2 (ru) 2018-01-31
PH12015000188A1 (en) 2017-01-09
ES2702629T3 (es) 2019-03-04
MY182000A (en) 2021-01-18
TR201819806T4 (tr) 2019-01-21
CA2893321C (en) 2018-08-07
PH12015000188B1 (en) 2019-02-01

Similar Documents

Publication Publication Date Title
AU364914S (en) A rollator
AU360248S (en) A flask
GB201410044D0 (en) A game system
PT3107946T (pt) Poliiso-ureia
GB201420579D0 (en) Walker for moving a structure
GB201519623D0 (en) A platform
GB201402247D0 (en) A footgauge
GB201512932D0 (en) A Nebuliser
PT3085370T (pt) Calebina a para induzir a lipólise
GB2525617B (en) A guard
AU364935S (en) Breastshield for a breastpump
GB201517502D0 (en) Positioning means
GB201504091D0 (en) A nebuliser
GB201415844D0 (en) A Support
GB201402623D0 (en) A hooklink system
PL3264899T3 (pl) Mykoherbicyd
ZA201605329B (en) A support
AU201517057S (en) A top
AU201613064S (en) A jacket
GB201511598D0 (en) Dividing a group
GB201411681D0 (en) Concept a
AU358214S (en) A jacket
SG10201404484XA (en) A positioning system
AU362032S (en) A jacket
AU362035S (en) A jacket